Advancing the Future of RNA Therapeutics Through Process Analytical Technology

ReciBioPharm introduces an advanced process analytical technology (PAT) platform for RNA therapeutics that leverages in-line PAT and machine learning to enable real-time monitoring, control, and optimisation. PAT tools provide continuous data throughout the production process – from plasmid linearisation to sterile fill/finish – allowing for immediate adjustments and enhanced product quality. A centralised Knowledge Hub integrates these data streams, enabling predictive process control that reduces the need for physical experimentation and accelerate development timelines. By combining process development and manufacturing into a digitally integrated framework, this approach shortens RNA development from months to weeks and supports both lab-scale and cGMP production. The platform is designed for scalability and adaptability, with potential applications across a range of advanced therapies.